nimesulide and gsk-2816126

nimesulide has been researched along with gsk-2816126 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beijersbergen, RL; Cesaroni, M; Company, C; Gargiulo, G; Hulsman, D; Lieftink, C; Morris, B; Proost, N; Schmitt, MJ; Serresi, M; Siteur, B; van Lohuizen, M	1

Other Studies

1 other study(ies) available for nimesulide and gsk-2816126

Article	Year
Ezh2 inhibition in Kras-driven lung cancer amplifies inflammation and associated vulnerabilities. The Journal of experimental medicine, 2018, 12-03, Volume: 215, Issue:12 Topics: A549 Cells; Animals; Bortezomib; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Enhancer of Zeste Homolog 2 Protein; Humans; Indoles; Inflammation; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Proto-Oncogene Proteins p21(ras); Pyridones; Sulfonamides	2018

Article

Year

Ezh2 inhibition in Kras-driven lung cancer amplifies inflammation and associated vulnerabilities.

The Journal of experimental medicine, 2018, 12-03, Volume: 215, Issue:12

Topics: A549 Cells; Animals; Bortezomib; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Enhancer of Zeste Homolog 2 Protein; Humans; Indoles; Inflammation; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Proto-Oncogene Proteins p21(ras); Pyridones; Sulfonamides

2018